
"EUTULAPriority claimed from 18/04/2022; Application No. : 97368158 ;United States of America" is still moving through the registration pipeline. Most applications hit at least one hurdle — objection, opposition or a hearing — and deadlines at each stage are short. Get notified the moment the status changes.
| Trademark | EUTULAPriority claimed from 18/04/2022; Application No. : 97368158 ;United States of America |
| Trademark Type | Wordmark |
| Class | 5 |
| Application Number | 5647438 |
| Nature/Scope of business | Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders. |
| Publication | In Journal No. 2101 |
| Status | Unknown |
| Applicant: | AbbVie Inc. |
| Applicant Address | 1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, ILLINOIS 60064, USA A Company Organised and Existing Under the Laws of the State of Delaware, United States of America; Manufacturers and Merchants |
| Jurisdiction | DELHI |
| Agent | ZEUSIP ADVOCATES LLP |
| Agent Address | C-4, Jangpura Extension, New Delhi-110014 |
Get your trademark registered with expert guidance. Limited time offer!
File NowComprehensive analysis of your trademark search delivered to your phone
What you'll get: